TREASURE GLOBAL INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TREASURE GLOBAL INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.33M | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | $22.07M | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | $69.41M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $79.67M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $14.02M | Dec 5, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $69.41M | Sep 28, 2023 |
| FY2023 | Jun 30, 2022 | $79.67M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $14.02M | Dec 5, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.67M | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | $816.1K | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | $523.3K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $476.2K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $139.9K | Dec 5, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($23.38M) | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | ($6.59M) | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | ($11.73M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($11.75M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($7.92M) | Dec 5, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($22.03M) | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | ($6.06M) | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | ($10.24M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($10.18M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($7.59M) | Dec 5, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $215.9K | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | $513.5K | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | $549.1K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $266.7K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $435.5K | Dec 5, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($9.48M) | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | ($4.71M) | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | ($9.56M) | Sep 30, 2024 |
| FY2023 | Mar 31, 2023 | $9.60M | Sep 28, 2023 |
| FY2023 | Jun 30, 2022 | ($8.66M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($6.80M) | Dec 5, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $14.8K | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | $16.7K | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | $87.0K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $312.4K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $84.9K | Dec 5, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $14.87M | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | $4.28M | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | $6.37M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $2.70M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $3.69M | Dec 5, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.13M | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | $897.9K | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | $6.50M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $18.30M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $10.21M | Dec 5, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $10.74M | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | $3.38M | Oct 16, 2025 |
| FY2025 | Jun 30, 2023 | ($130.3K) | Oct 16, 2025 |
| FY2024 | Jun 30, 2022 | ($15.60M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2021 | ($6.52M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2020 | $420.7K | Dec 5, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($61.41M) | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | ($38.03M) | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | ($31.44M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($19.72M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($7.97M) | Dec 5, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $4.59M | Sep 28, 2023 |
| FY2023 | Jun 30, 2022 | $1.85M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $2.84M | Dec 5, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (19) | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | (383) | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | (49) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | (1) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Dec 5, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (19) | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | (383) | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | (49) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | (1) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Dec 5, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 4.15M | Oct 16, 2025 |
| FY2025 | Jun 30, 2024 | 33,432 | Oct 16, 2025 |
| FY2024 | Jun 30, 2023 | 255,734 | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 10.55M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 10.31M | Dec 5, 2022 |